Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

I.V Papavrine for Labor Induction in Term PROM: A Prospective Randomized Controlled Trial

NCT07517796 is registered in ClinicalTrials.gov with Western Galilee Hospital-Nahariya as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07517796 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
I.V Papavrine for Labor Induction in Term PROM: A Prospective Randomized Controlled Trial
Lead sponsor
Western Galilee Hospital-Nahariya
Phase
Phase 4
Overall status
Recruiting
Start date
October 22, 2025
Completion date
October 22, 2027
Enrollment
110 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

premature rupture of membranes